These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 21471841)
1. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations. Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841 [TBL] [Abstract][Full Text] [Related]
2. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750 [TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells. Stapleton CJ; Armstrong DL; Zidovetzki R; Liu CY; Giannotta SL; Hofman FM Neurosurgery; 2011 May; 68(5):1342-53; discussion 1353. PubMed ID: 21307796 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Gault J; Sain S; Hu LJ; Awad IA Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691 [TBL] [Abstract][Full Text] [Related]
5. YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM). Shi Y; Song Y; Liu P; Li P J Clin Neurosci; 2019 Jun; 64():220-226. PubMed ID: 30948312 [TBL] [Abstract][Full Text] [Related]
6. Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Zhao Y; Tan YZ; Zhou LF; Wang HJ; Mao Y Stroke; 2007 Apr; 38(4):1313-9. PubMed ID: 17322085 [TBL] [Abstract][Full Text] [Related]
7. Endothelial cells from human cerebral aneurysm and arteriovenous malformation release ET-1 in response to vessel rupture. Boscolo E; Pavesi G; Zampieri P; Conconi MT; Calore C; Scienza R; Parnigotto PP; Folin M Int J Mol Med; 2006 Nov; 18(5):813-9. PubMed ID: 17016610 [TBL] [Abstract][Full Text] [Related]
16. Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor. Jung KH; Chu K; Jeong SW; Park HK; Bae HJ; Yoon BW Arch Neurol; 2003 Nov; 60(11):1613-8. PubMed ID: 14623736 [TBL] [Abstract][Full Text] [Related]
17. Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells. Detter MR; Snellings DA; Marchuk DA Circ Res; 2018 Oct; 123(10):1143-1151. PubMed ID: 30359189 [TBL] [Abstract][Full Text] [Related]
18. Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs). Min W; Zhou JH Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35667709 [TBL] [Abstract][Full Text] [Related]
19. Study of CCM Microvascular Endothelial Phenotype by an In Vitro Tubule Differentiation Model. Delle Monache S; Retta SF Methods Mol Biol; 2020; 2152():371-375. PubMed ID: 32524565 [TBL] [Abstract][Full Text] [Related]
20. GLYOXALASE I A111E, PARAOXONASE 1 Q192R AND L55M POLYMORPHISMS IN ITALIAN PATIENTS WITH SPORADIC CEREBRAL CAVERNOUS MALFORMATIONS: A PILOT STUDY. Rinaldi C; Bramanti P; Famà A; Scimone C; Donato L; Antognelli C; Alafaci C; Tomasello F; D'Angelo R; Sidoti A J Biol Regul Homeost Agents; 2015; 29(2):493-500. PubMed ID: 26122242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]